News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Trinity Biotech (NASDAQ:TRIB) has secured an additional $7.0 million investment from Perceptive Advisors, its largest financial investor, comprising $2.5 million in new debt and $4.5 million in capitalized interest. This funding will support the company's CGM+ continuous glucose monitoring platform, Trinovium subsidiary, and diagnostics …
Trinity Biotech (NASDAQ: TRIB) has secured an additional $7.0 million investment from Perceptive Advisors, its largest financial investor, and has regained compliance with Nasdaq's minimum bid price requirement. The investment, consisting of new debt funding and capitalized interest, aims to bolster liquidity for strategic …
Nutriband Inc. announced that its CEO and Co-Founder, Gareth Sheridan, will present at the 2026 Georgia Life Sciences Summit on August 26th. The summit brings together leaders in life sciences to showcase Georgia's innovation in biotechnology, medical technology, research, manufacturing, and investment. Nutriband's presentation …
Bruchou & Funes de Rioja advised YPF S.A. on the sale of its 70% stake in MetroGAS S.A. and 5% in MetroENERGÍA S.A. to Empresa Distribuidora y Comercializadora Norte S.A. (EDENOR). The transaction, which followed a competitive process organized by Citibank N.A., is pending …
This article first appeared on GuruFocus. Recurring Adjusted EBITDA: Reached $1.99 billion, up 1.4% year-over-year. Recurring Adjusted Net Income: Totaled $88 million in the quarter, down 80% compared to the second quarter of '25. Net Debt: Reached $32.5 billion at the end of June. …
Sharemaestro market context Price below Trend Line 52 weeks -32.3% · Next-week setup negative 28.1%The article provides an earnings forecast for Nutriband Inc (NTRB), indicating a current earnings forecast score of 8.00 and an average price target of $15.00 based on one analyst. The analyst recommends a "Buy" rating for NTRB, suggesting a potential upside of over 370%.
Distribution Solutions Group (DSGR) recently saw its stock rally by nearly 30%, though its Q2 earnings, showing increased revenue and EPS, were met with a flat market reaction due to lingering concerns about interest costs. While bulls point to improved net margins and the …
This article provides an earnings forecast for Trinity Biotech PLC (TRIB), focusing on future EPS and revenue growth estimates. It includes current stock information, market cap, and a comparison with peer companies in the healthcare equipment sector. The data presented was last updated on …
Search by ticker symbol or company name and select a result to open its chart.